You are here:- Resources .. Resource Centre .. HCV .. HCV Testing policies in the WHO European region

HCV Testing policies in the WHO European region

Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign 
C. Orkin, S. Flanagan, E. Wallis, G. Ireland, R. Dhairyawan, J. Fox, R. Nandwani, R. O'Connell, M. Lascar, J. Bulman, I. Reeves, A. Palfreeman, G. R. Foster, K. Ahmad, J. Anderson, C. Y. Tong and S. Lattimore
HIV medicine Mar 2016;17(3):222-30. doi: 10.1111/hiv.12364

Hepatitis B and C surveillance and screening programmes in the non-EU/EEA Member States of the WHO European Region: survey findings from 10 countries, 2012 
A. Mozalevskis, I. Eramova, K. Safreed-Harmon and J. V. Lazarus
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin Jun 2 2016;21(22):. doi: 10.2807/

Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries 
P. J. Easterbrook
Journal of hepatology Oct 2016;65(1 Suppl):S46-66. doi: 10.1016/j.jhep.2016.08.002

HIV and Hepatitis Testing: Global Progress, Challenges, and Future Directions 
P. Easterbrook, C. Johnson, C. Figueroa and R. Baggaley
AIDS reviews Jan-Mar 2016;18(1):3-14. doi:

Achieving WHO recommendations for Hepatitis C Virus Elimination in Belgium 
S. Bourgeois, S. Blach, C. Blach, W. Laleman, C. Mathei, J. P. Mulkay, H. Ravazi, G. Robaeys, P. Starkel, P. Van Damme, H. Van Vlierberghe, D. Vandijck and C. Vandijck
Acta gastro-enterologica Belgica Apr-Jun 2016;79(2):222-6. doi:

2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV 
J. Bottero, C. Brouard, F. Roudot-Thoraval, S. Deuffic-Burban, P. Hofliger, A. Abergel, J. Volant, D. Dhumeaux and Y. Yazdanpanah
Liver international : official journal of the International Association for the Study of the Liver Oct 2016;36(10):1442-9. doi: 10.1111/liv.13135

WHO Guidelines Approved by the Guidelines Review Committee 

2016;():. doi:

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus 

Hepatology (Baltimore, Md.) Sep 2015;62(3):932-54. doi: 10.1002/hep.27950

Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey 
A. Bechini, A. Falla, A. Ahmad, I. Veldhuijzen, S. Boccalini, B. Porchia and M. Levi
BMC infectious diseases 2015;15():353. doi: 10.1186/s12879-015-1104-8

Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage 
J. Bottero, A. Boyd, J. Gozlan, F. Carrat, J. Nau, M. D. Pauti, H. Rougier, P. M. Girard and K. Lacombe
Open forum infectious diseases Dec 2015;2(4):ofv162. doi: 10.1093/ofid/ofv162

The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014 
C. Brouard, Y. Le Strat, C. Larsen, M. Jauffret-Roustide, F. Lot and J. Pillonel
PloS one 2015;10(5):e0126920. doi: 10.1371/journal.pone.0126920

Global policy and access to new hepatitis C therapies for people who inject drugs 
J. S. Doyle, E. J. Aspinall, S. J. Hutchinson, B. Quinn, C. Gore, S. Z. Wiktor and M. E. Hellard
The International journal on drug policy Nov 2015;26(11):1064-71. doi: 10.1016/j.drugpo.2015.05.008

Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries 
N. Ford, S. Wiktor, K. Kaplan, I. Andrieux-Meyer, A. Hill, P. Radhakrishnan, P. Londeix, C. Forette, A. Momenghalibaf, A. Verster and T. Swan
The International journal on drug policy Nov 2015;26(11):1088-93. doi: 10.1016/j.drugpo.2015.05.004 Epub 2015 May 18

Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling Techniques 
C. Geue, O. Wu, Y. Xin, R. Heggie, S. Hutchinson, N. K. Martin, E. Fenwick and D. Goldberg
PloS one 2015;10(12):e0145022. doi: 10.1371/journal.pone.0145022

[Community-based screening: a motivating experience for drug users] 
L. Grammatico-Guillon, E. Arnault, S. Rollier, G. Bonnemaison, F. Dubois and E. Rusch
Sante publique (Vandoeuvre-les-Nancy, France) Sep-Oct 2015;27(5):633-9. doi:

[Chronic disease and treatment burden for patients: the example of hepatitis C] 
D. Lhuilier, F. Brugeilles and D. Rolland
Sante publique (Vandoeuvre-les-Nancy, France) Jan-Feb 2015;27(1 Suppl):S17-21. doi:

Epidemiology of hepatitis C in Croatia in the European context 
T. Vilibic-Cavlek, J. Kucinar, B. Kaic, M. Vilibic, N. Pandak, L. Barbic, V. Stevanovic and J. Vranes
World journal of gastroenterology Aug 28 2015;21(32):9476-93. doi: 10.3748/wjg.v21.i32.9476

Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey 
A. Spina, I. Eramova and J. V. Lazarus
BMC infectious diseases 2014;14 Suppl 6():S15. doi: 10.1186/1471-2334-14-s6-s15 Epub 2014 Sep 19

WHO Guidelines Approved by the Guidelines Review Committee 

2014;():. doi:

[Recent developments in serologic and molecular diagnosis of hepatitis B and C] 
M. Poljak, S. Z. Lepej and O. D. Rode
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti Oct 2013;67(4):281-90. doi:

Adherence to screening guidelines for hepatitis C among HIV-positive patients 
S. Jonckheere, A. Vincent, L. Belkhir, D. Wilmes, B. Vandercam and J. C. Yombi
AIDS patient care and STDs Jun 2013;27(6):317-9. doi: 10.1089/apc.2013.0096 Epub 2013 May 19

Predicted effects of treatment for HCV infection vary among European countries 
S. Deuffic-Burban, P. Deltenre, M. Buti, T. Stroffolini, J. Parkes, N. Muhlberger, U. Siebert, C. Moreno, A. Hatzakis, W. Rosenberg, S. Zeuzem and P. Mathurin
Gastroenterology Oct 2012;143(4):974-85.e14. doi: 10.1053/j.gastro.2012.05.054

2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines 

Liver international : official journal of the International Association for the Study of the Liver Feb 2012;32 Suppl 1():2-8. doi: 10.1111/j.1478-3231.2011.02703.x

AHRQ Comparative Effectiveness Reviews Screening for Hepatitis C Virus Infection in Adults 
M. Eisenberg Center for Clinical Decisions John and Science Communications
2007;():. doi:

 New EU project
Friday, September 01, 2017

CHIP will be the coordinator for the new EU funded Joint Action INTEGRATE. The launch of INTEGRATE will happen in Brussels 19 September 2017 where the EU commissioner for Food and Health will participate.
Read more here

 Late presentation of chronic viral hepatitis for medical care: a consensus definition
Monday, May 08, 2017

New publication! Late presentation of chronic viral hepatitis for medical care: a consensus definition. Read the full article here.

 Two-day short course on Introduction to Cost-effectiveness Analysis for Infectious Diseases at UCL
Tuesday, April 04, 2017

Don't miss out! Join a two-day short course on Introduction to Cost-effectiveness Analysis for Infectious Diseases at UCL. The course takes place on 28 and 29 September 2017. Read more here.

 Evaluation of the HepHIV 2017 Conference
Monday, April 03, 2017

The evaluation report from the HepHIV conference is now available. You can access it here.

 The HIV in Europe 2016 Annual Report is now available!
Monday, April 03, 2017

You can now read about our 2016 projects, activities and achievements in our annual report. Find it here.

 New report: The HIV in Europe initiative - the first 10 years
Tuesday, January 31, 2017

2017 marks 10 years of HIV in Europe - read about the 10 years of working with different stakeholders to promote earlier testing and care in our new report

 HepHIV 2017 Malta Conference
Tuesday, January 31, 2017

HepHIV 2017 Conference is now taking place in Malta (31 January - 2 February 2017). See full programme here. You can also follow news and updates on Twitter by following the conference hashtag #HepHIV2017


Copyright 2009 by HIV in Europe